NueHealth, GeneNews partner to offer patients early CRC detection: 3 notes

NueHealth has entered a three-year partnership agreement with GeneNews — a Canadian diagnostic products company — to offer its patients early cancer detection tests.

Here's what you need to know:

1. Patients of NueHealth's provider networks will have access to three screening types, including ColonSentry, a screening test that provides early risk stratification for colorectal cancer.

2. ColonSentry utilizes a blood test, which measures the expression of gene biomarkers that are early warning signs of colorectal cancer.

3. The tests will be processed by GeneNews at a clinical reference lab in Richmond, Va.

More articles on gastroenterology and endoscopy:
Vitamin A metabolite may suppress colorectal cancer: 5 study insights
Hannibal Regional Medical Group adds Dr. Ashraf Almashhrawi: 5 things to know
Migraines associated with GI disorders: 5 study insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months